"Our analysis of a large national database revealed that adding radiation therapy
to androgen-deprivation therapy decreased the risk of death in these
patients by 50 percent over five years," says Jason Efstathiou, MD,
DPhil, of the MGH Cancer Center and Department of Radiation Oncology,
senior author of the study. "It appears that more aggressive local
management of prostate cancer confined to the pelvis can offer more
durable disease control, prevent the disease from spreading further and,
for some patients, even provide a potential cure."
This site is for information on the various Chemo treatments and Stem Cell Therapies since 1992. This journey became bitter sweet in 2014, with the passing of my beautiful and dear wife. Sherry, had fought Non - Hodgkins Lymphoma(NHL) since 1990, in and out of remissions time and time again. From T-Cell therapies(1990's) to Dual Cord Blood Transplant(2014), she was in Clinical Trials over the years. This site is for informational purpose only and is not to promote the use of certain therapies.
Tuesday, May 12, 2015
Radiation and hormonal therapy improves survival Prostate Cancer
A new study finds that men with Prostate Cancer that has spread to
nearby lymph nodes, who have a significant risk of dying from the
disease, can benefit from the addition of radiation therapy to
treatments that block the effects of testosterone. The findings imply
that the almost half of patients with node-positive disease nationwide
who this study found had not received combination therapy were not
receiving the treatment that could best control their tumor and possibly
save their lives "Our analysis of a large national database revealed that adding
radiation therapy to androgen-deprivation therapy decreased the risk of
death in these patients by 50 percent over five years," says Jason
Efstathiou, MD, DPhil, of the MGH Cancer Center and Department of
Radiation Oncology, senior author of the study. "It appears that more
aggressive local management of prostate cancer confined to the pelvis
can offer more durable disease control, prevent the disease from
spreading further and, for some patients, even provide a potential
cure."
"Our analysis of a large national database revealed that adding radiation therapy
to androgen-deprivation therapy decreased the risk of death in these
patients by 50 percent over five years," says Jason Efstathiou, MD,
DPhil, of the MGH Cancer Center and Department of Radiation Oncology,
senior author of the study. "It appears that more aggressive local
management of prostate cancer confined to the pelvis can offer more
durable disease control, prevent the disease from spreading further and,
for some patients, even provide a potential cure."
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment